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ABSTRACT
 Across species overweight and obesity are associated with numerous disorders. To evaluate the occurrence 
of disturbances in terms of canine overweight and obesity, the authors undertook a prospective examination 
of hematological and biochemical parameters in 45 overweight and obese dogs, and compared the data with 
those obtained in 28 healthy normal-weight dogs. Neutrophil count, total cholesterol concentration and alkaline 
phosphatase activity were increased in the total group of overweight and obese dogs (P<0.01; P<0.007; 
P<0.000007), while concentrations of blood urea nitrogen decreased (P<0.007). Overweight was characterized 
by increased neutrophil count, cholesterol and triglycerides (P<0.03; P<0.00005; P<0.02), while obesity 
resulted in an increase in glucose, alkaline phosphatase and total cholesterol (P<0.02; P<0.002; P<0.0004), and 
a decrease in blood urea nitrogen and creatinine (P<0.0004; P<0.004). The obtained results support the idea that 
neutrophils could be involved in canine obesity-related pathology. Overweight and obesity were characterized 
by disturbances in the glucose metabolism and dyslipidemia. One of the interesting aspects of our examination 
was that obesity in dogs was related to a decrease in urea and creatinine concentrations in the circulation, which 
may be a consequence of increased glomerular fi ltration or hyperlipidemia. This study implies that canine 
obesity signifi cantly affects alkaline phosphatase activity. A favorable circumstance related to the epidemic 
proportions of obesity in dogs is that most related potential health problems can be successfully prevented by 
maintaining a normal body weight.
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Introduction 
Overweight and obesity have reached epidemic rates today and represent a major 
health problem in human and veterinary medicine. Recent studies have shown that between 
40 % - 55 % of dogs are overweight, with a continuous upward trend (SWITONSKI and 
MANKOWSKA, 2013; DE GODOY and SWANSON, 2013). This condition affects dogs and 
other pets adversely in many ways. It is associated with increased incidence of numerous 
diseases, such as: impairment of glucose metabolism, osteoarthritis, orthopedic diseases, 
abnormalities in circulating lipid profi les, cardiorespiratory diseases, urinary and 
reproductive disorders, increased mortality risk, dermatological and respiratory diseases, 
anesthetic complications and increased occurrence of various neoplasms (GERMAN, 2006). 
In recent years, the nature of fat deposits has become better understood. Long regarded 
as just physiologically inert energy-storage, adipose tissue is now generally accepted as 
an important endocrine organ, with numerous metabolic activities. White adipose tissue 
secretes biologically active substances called ‘’adipokines” (ATHYROS et al., 2010). The 
majority of adipokines act as proinfl ammatory cytokines, resulting in a persistent state of 
low-grade infl ammation (SCHÄFFLER and SCHÖLMERICH, 2010; CHMELAR et al., 2013). 
Hematology laboratory tests have long been used in canine medicine in the assessment 
of health. Despite the widespread problems of overweight and obesity in canine 
medicine, studies examining the effects of naturally-gained obesity on hematological and 
biochemical parameters are scarce. Chronic infl ammation affects many hematological 
parameters, including erythrocytes, leukocytes and platelets (CHEN at al., 2013). Moreover, 
the most common cause of anemia in dogs is the infl ammatory state. In spite of the fact 
that anemia caused by infl ammation is commonly found in veterinary and human cases, 
the underlying mechanism has not yet been completely understood (CHIKAZAWA et al., 
2013). In addition to being a common cause of anemia, pro-infl ammatory cytokines are 
potent inducers of leukocyte production. 
In addition to hematological disturbances, there is a great deal of evidence 
demonstrating that overweight and obesity are related to dysregulation of glucose and 
lipid metabolism (RAND et al., 2004). Abdominal obesity and impaired postprandial lipid 
metabolism have long been recognized as being associated with atherosclerosis and 
coronary heart disease in humans (FREEDMAN et al., 2001; FOLSOM et al., 1998), while 
in dogs atherosclerosis, coronary heart disease and stroke are rare and not known to be 
associated with obesity (VERKEST, 2014a). Moreover, although obesity is known to cause 
insulin resistance, there is no current data proving that obesity is actually a risk factor for 
diabetes mellitus in this species (RAND et al., 2004). 
Across different species, obesity is associated with numerous disorders, but in canine 
medicine little information is available on the impact of chronic overweight and obesity 
on blood cell number, hematological indices and biochemical parameters evaluating 
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kidney and liver function. Thus, the objective of this study was to examine the relationship 
of overweight and obesity with hematological and biochemical parameters in generally 
healthy overweight and obese dogs. 
Materials and methods
Animals. A total of 45 overweight and obese, but otherwise healthy dogs and 28 
healthy, normal-weight dogs were included in this prospective study. The dogs were 
randomly selected from overweight and obese dogs among the patients of the “Branimir” 
veterinary clinic, Zagreb. Various breeds were represented, but Labradors and Golden 
Retrievers were the most frequent breeds in both groups. There were 30 females and 
15 males in the overweight and obese group (O), and 14 females and 14 males in the 
normal-weight control group (C). A detailed history of all animals was obtained. All the 
dogs had been overweight or obese for at least for 6 months. Exclusion criteria were any 
ongoing medical therapies and concomitant chronic or acute illnesses. The weight status 
of the dogs was determined by the body condition score (BCS), always assessed by the 
same veterinarian, using a 5-point scale (LAFLAMME, 1997). The weight of the dogs 
was compared with the standard weight for the breed, and rib palpation, waist visibility 
and abdomen tucking were used to determine BCS. The normal-weight dogs with BCS 
3 represented the control group (C), BCS 4 represented overweight (O1) dogs and BCS 
5 represented obese (O2) dogs. There were 26 animals with BCS 4 and 19 animals with 
BCS 5. Control dogs with BCS 3 were deemed healthy, on the basis of normal history, 
complete physical examination and laboratory data: complete blood count, serum 
biochemistry and urinalysis. The study protocol was approved by the Ethics Committee 
for Animal Experimentation, Faculty of Veterinary Medicine, and University of Zagreb, 
Croatia. All the dogs’ owners gave written informed consent before entering the study. 
Laboratory analysis. Blood was collected after an overnight fast via cephalic 
venipuncture into Vacutainer EDTA tubes (Becton Dickinson, Rutherford, NJ). Red 
blood cell count (RBC), white blood cell count (WBC), hemoglobin concentration (HB), 
mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC) 
and red cell distribution width (RDW) were evaluated using a “Horiba ABX automatic 
blood cell counter (Diagnostics, Montpellier, France) and the original manufacturer’s 
reagents. Blood cell morphology and WBC differential count were evaluated in Wright 
stained blood fi lms. Creatinine (CRE), blood urea nitrogen (BUN), glucose (GLUC), 
total cholesterol (tCHOL), and triglyceride (TRIG) concentrations, and the activities of 
aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyl 
transferase (GGT) and alkaline phosphatase (ALP) were measured in sera samples, using 
an Olympus AU600 biochemical autoanalyser (Olympus Corporation, Tokyo, Japan) 
with the manufacturer’s reagents and standard methods. 
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Data analysis. Normal distribution of all variables was tested using the Kolmogorov-
Smirnov test. Differences between obese and lean dogs were tested by either the Student t 
test or the Mann-Whitney U test. Statistical analyses were performed with computer 
software (Statistica for Windows, StatSoft Inc.), with the level of signifi cance set at P<0.05. 
Results 
All obtained hematological and biochemical results are shown as mean and standard 
deviation (SD). There were no statistically signifi cant differences between overweight, 
obese and normal-weight dogs regarding erythrocyte number and indices, or hematocrit 
and hemoglobin concentration (Table 1). 
Table 1. Red blood cell number and indices, hematocrit and hemoglobin concentration in normal 
weight, overweight and obese dogs (mean ± SD)
RBC
RDW
MCV MCH MCHC HB HTC
Group (×1012/L) (fL) (pg) (g/L) (g/L) (%)
C 6.9 ± 0.75 14 ± 1.1 71 ± 3.0 23 ± 1.6 330 ± 14 161 ± 17 49 ± 5.4
O 7.0 ± 0.72 14 ± 1.1 71 ± 3.2 24 ± 1.7 324 ± 57 167 ± 20 50 ± 5.2
O1 6.9 ± 0.62 14 ± 1.1 71 ± 2.9 24 ± 1.9 319 ± 73 164 ± 22 49 ± 4.8
O2 7.3 ± 0.79 14 ± 1.2 71 ± 3.8 23 ± 1.3 331 ± 16 171 ± 17 52 ± 5.5
RBC - red blood cells, RDW - red distribution width, MCV - mean cell volume, MCH - mean cellular hemoglobin, 
MCHC - mean cellular hemoglobin concentration, HB - hemoglobin concentration, HTC - hematocrit, C - 
control normal weight dogs (N = 28), O - total overweight and obese dogs (N = 45), O1 - overweight dogs (N = 
26), O2 - obese dogs (N = 19), *P<0.05 comparing O, O1 and O2 with C
No statistically signifi cant differences in the total leukocyte number and differential 
blood count were observed, except for neutrophils (NEU), being signifi cantly increased 
in the O (P<0.01) and O1 groups (P<0.03) while compared with C group (Table 2).
Table 2. Number of leukocytes and differential blood picture from normal weight, overweight and 
obese dogs (mean ± SD)
WBC NEU MO LY EO NS
Group (109/L) (%) (%) (%) (%) (%)
C 10 ± 2.8 58 ± 9.3 1.7 ± 2.2 35 ± 8.8 5.1 ± 4.3 0.04 ± 0.19
O 9.4 ± 2.7 65 ± 16* 1.6 ± 2.0 29 ± 15 4.2 ± 4.4 0.20 ± 0.41
O1 9.0 ± 2.6 65 ± 15* 1.3 ± 1.3 29 ± 14 4.4 ± 5.0 0.19 ± 0.40
O2 10 ± 2.7 64 ± 17 2.1 ± 2.7 29 ± 16 3.9 ± 3.6 0.22 ± 0.43
WBC - total leukocyte count, NEU - segmented neutrophils, MO - monocytes, LY - lymphocytes, EO - 
eosinophils, NS - nonsegmented neutrophils, C - control normal weight dogs (N = 28), O - total overweight 
and obese dogs (N = 45), O1 - overweight dogs (N = 26), O2 - obese dogs (N = 19), *P<0.05 comparing O, O1 
and O2 with C
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We found that tCHOL was signifi cantly elevated in the whole overweight and obese 
groups compared to the control normal-weight dogs (P<0.000007). Blood urea nitrogen 
signifi cantly decreased in the O (P<0.007) and O2 groups (P<0.0004), while CRE was 
lower only in the O2 group (P<0.004). Concentrations of GLUC showed a signifi cant 
increase in the O2 group (P<0.01), while TRIG was elevated in the O1 group, compared 
with the control lean dogs (P<0.02). The results are shown in Table 3. 
Table 3. Biochemical parameters in normal weight, overweight and obese dogs (mean ± SD)
BUN CRE BIL GLUK TRIG tCHOL
Group (mmol/L) (μmol/L) (μmol/L) (mmol/L) (mmol/L) (mmol/L)
C 6.6 ± 1.7 100 ± 11 3.7 ± 1.7 4.7 ± 0.8 1.1 ± 1.0 5.7 ± 1.1
O 5.3 ± 2.0* 92 ± 20 3.6 ± 1.7 5.7 ± 3.9 1.6 ± 1.5 8.1 ± 3.1*
O1 5.7 ± 2.3 95 ± 24 3.6 ± 1.7 6.0 ± 5.2 2.0 ± 1.8* 8.5 ± 3.7
O2 4.8 ± 1.5* 88 ± 15* 3.7 ± 1.8 5.2 ± 0.5* 1.2 ± 0.8 7.6 ± 2.2
BUN - blood urea nitrogen, CRE - creatinine, GLUC - glucose, BIL - total bilirubin, TRIG - triglyceride, 
tCHOL - total cholesterol, C - control normal weight dogs (N = 28), O - total overweight and obese dogs (N = 
45), O1 - overweight dogs (N = 26), O2 - obese dogs (N = 19), *P<0.05 comparing O, O1 and O2 with C
Activity of AST, ALT, YGT and ALP is shown in Table 4. The overweight and obese 
dogs displayed signifi cantly increased activity of ALP (P<0.007), while activities of AST, 
ALT and YGT remained similar compared with normal-weight dogs. The activity of ALP 
was signifi cantly increased in overweight (P<0.007) as well as obese dogs (P<0.002). 
Table 4. Enzyme activities in normal weight, overweight and obese dogs (mean ± SD)
AST ALT YGT ALP
Group (IU/L, 37 ºC) (IU/L, 37 ºC) (IU/L, 37 ºC) (IU/L, 37 ºC)
C 34 ± 8.3 53 ± 27 3.3 ± 2.1 42 ± 25
O 36 ± 12 98 ± 190 5.3 ± 9.6 231 ± 427*
O1 38 ± 14 119 ± 244 6.7 ± 13 243 ± 506*
O2 35 ± 9.9 68 ± 66 3.3 ± 1.8 216 ± 305*
AST - aspartate aminotransferase, ALT - alanine aminotransferase, YGT - gamma glutamyl transferase, ALP - 
alkaline phosphatase, C - control normal weight dogs (N = 28), O - total overweight and obese dogs (N = 45), 
O1 - overweight dogs (N = 26), O2 - obese dogs (N = 19), *P<0.05 comparing O, O1 and O2 with C
Discussion
Although determination of blood cell count and hematological indices are today 
widely available and inexpensive, there is a paucity of research focusing on blood cells in 
spontaneously overweight and obese dogs. In addition, the results of research conducted 
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on humans and animals published so far regarding the association between obesity and 
hematological disturbances, have been inconsistent. 
It is now well-established that obesity results in a state of chronic low-grade 
infl ammation (SOLINAS and KARIN, 2010). We hypothesized that dogs with a higher body 
condition score would have decreased RBCs, HB and HTC due to the chronic infl ammatory 
state, but overweight and obese dogs showed normal hematology regarding RBC count, 
RBC related indices HB and HTC. Similar to our fi ndings, some researchers found no 
relationship between anemia and obesity in rodents (HARISHANKAR et al., 2011) while 
in obese humans there was higher risk of development of anemia (TUNGTRONGCHITR 
et al., 2000). In contrast to our results, studying the impact of obesity on HTC and HB 
levels some authors concluded that obese individuals have even higher values compared 
to normal-weight individuals (RAO and MORGHOM, 1986; ZHANG et al., 2010; ORNELAS 
et al., 2011). Despite some indicators of proinfl ammatory status (increased NEU), weight 
excess in the investigated dogs was not associated with impairment of red blood cell 
count. 
No signifi cant differences were found between the groups with respect to total 
WBC count and differential blood count. The exception was NEU, being signifi cantly 
increased in the overweight population in comparison with lean control dogs. This is in 
agreement with the study by RYDER et al. (2014), who found that neutrophils correlated 
positively with increased visceral fat in humans. The results of MAHASSNI and SEBAA 
(2012) also showed signifi cant increases in NEU, LY and total WBCs counts in obese 
states in humans. Researching obesity in cats, JASO-FRIEDMANN et al. (2008), found 
no differences in WBC, NEU or LY counts between obese and lean cats. As the fi rst 
immune cells to respond to infl ammation, NEU have been recently implicated in obesity 
(CHMELAR et al., 2013), but the exact role of proinfl ammation in canine overweight and 
obesity is currently unknown. Adipose tissue dysfunction is found to be associated with 
systemic low-grade infl ammation (SCHÄFFLER and SCHÖLMERICH, 2010). Having 
a short life span, NEU indicates the continuous activation of the immune system and 
chronic low-grade infl ammation associated with canine overweight and obesity. In 
addition to an infl ammatory state, one of the possible causes of increased NEU is the 
hypercholesterolemia that was present in both the investigated groups, the overweight 
and obese dogs. Namely, it was shown that an increase in tCHOL induces elevation of 
blood NEU (YVAN-CHARVET et al., 2008; DRECHSLER et al., 2010). 
The effect of overweight and obesity on metabolic parameters has not been 
reported extensively in dogs, and most research evaluating the impact of obesity on 
biochemical indicators in dogs has been conducted on experimental models. Moreover, 
the pathophysiological associations between obesity and renal dysfunction are less well 
understood. Serum concentrations of BUN were lower in all the overweight and obese 
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dogs, as well as in obese dogs. Lower CRE concentrations in comparison to the lean 
dogs, were only observed in the obese group. There are two possible explanations. It 
is widely accepted that CRE concentrations may serve as an indicator of muscle mass 
(HJELMESATH et al., 2010). Thus, decreased CRE in obese dogs could be the consequence 
of lower muscle mass volume in relation to proliferated adipose tissue. Researching obesity 
in humans, numerous authors have agreed that obesity may be considered to be a state 
of relative hyperfi ltration (RITZ, 2008; LAVILLE, 2011; WICKMAN and KRAMER, 2013). 
The factors involved could be: energy intake (high protein and salt), hyperinsulinemia, 
and enhanced tubuloglomerular feedback because of increased sodium reabsorption 
(RUTKOWSKI et al., 2006). In addition, some authors speculate that the decrease of BUN 
and CRE concentrations, as a consequence of increased glomerular hyperfi ltration, 
may be associated with increased metabolic risk and diabetes development in humans 
(TOMASEWSKI et al., 2007; LORENZO et al., 2009). Therefore, the importance of lower 
BUN and CRE concentrations in canine obesity should not be underemphasized. 
Weight excess, disturbances in glucose metabolism and dyslipidemias are some of the 
components of the metabolic syndrome. To date only a few epidemiological studies have 
been performed to defi ne this condition in canine obesity. Serum glucose concentration 
was only elevated in obese dogs, while overweight dogs retained normal glucose 
concentrations, compared with those obtained in normal-weight dogs. Researching 
metabolic changes in canine obesity, PENA et al. (2014) also concluded that weight excess 
is characterized by an increase in serum glucose. Overweight and obesity in dogs have 
been well-accepted as causes of insulin resistance (LARSON et al., 2003; GAYET et al., 
2004; VERKEST et al., 2011). However, insulin resistance in dogs could be present without 
overt signs of diabetes (ZORAN, 2010). Moreover, it appears that very few dogs develop 
overt diabetes as a consequence of obesity-induced insulin resistance (RAND, 2004). In 
addition, there are no current data proving that obesity is actually a risk factor for DM 
in canines (GERMAN, 2006). Taken together, further epidemiological data examining 
the relationship between canine diabetes and obesity are needed, to clarify the possible 
mechanisms involved in impairment of glucose homeostasis in the condition of adipose 
tissue proliferation. 
Hyperlipidemia is one of the common metabolic disorders observed in obesity in 
humans and animals (DE GODOY and SWANSON, 2013). Our results showed elevated 
tCHOL concentrations in the overweight and obese groups together and the obese 
group. Concentrations of TRIG were only increased in the overweight group. Secondary 
hyperlipidemia represents the most common form of canine dyslipidemia that may be 
a result of obesity (PANAGIOTIS and STEINER, 2010). Published data studying canine 
overweight and obesity have also confi rm that lipid alterations may occur, with increases 
in cholesterol and triglyceride concentrations (PENA et al., 2014; VEIGA et al., 2008). In spite 
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of the fact that obese dogs develop increased circulating concentrations of triglycerides 
and cholesterol, they do not develop atherogenic changes. Namely, atherosclerosis, 
coronary heart disease and stroke are rare and are not known to be associated with obesity 
in dogs (VERKEST, 2014), so it would be interesting to analyze what proteins in circulation 
or endothelium are included in such protection. 
The four enzymes that are most commonly used in evaluating canine liver function 
are ALT, AST, YGT and ALP. Elevated serum hepatic enzyme activities may be associated 
with a high prevalence of fatty liver, which is frequently observed in obese humans 
(CHOI, 2003). No signifi cant differences in AST, ALT and YGT activity were observed 
between overweight, obese and the normal lean, control dogs, while activity of ALP was 
signifi cantly increased in overweight and obese dogs. A similar increase in ALP activity 
in obese rats was observed by MOZEŠ et al. (2004). The authors concluded that changes in 
ALP activity might be a consequence of overnutrition. Moreover, comparing the impact 
of a weight-loss program on canine ALP activity, some authors concluded that the activity 
of this enzyme signifi cantly decreases after a successful weight-loss program (PENA et 
al., 2014). In contrast to our observations, some researchers have reported that abnormal 
serum levels of hepatic enzymes, such as ALT and YGT, are frequently found in obese 
dogs (TRIBUDDHARATANA et al., 2011). The results obtained indicated that there was no 
evidence of liver damage in canine overweight and obesity. Alkaline phosphatase, as an 
enzyme functionally involved in fat absorption and the transport of long-chain fatty acids 
in the intestinal mucosa (BERNARD et al., 1992), could be elevated in overweight and 
obese dogs due to overfeeding. 
The incidence of obesity in dogs has assumed epidemiological proportions and 
potentially represents a major health problem in veterinary medicine. A comforting fact in 
addressing potential health problems related to obesity is that this problem can be simply 
resolved with successful weight-loss and appropriate prevention. Our results support 
the idea that NEU are involved in obesity-related pathology, and they extend previous 
fi ndings in human and animals that accumulation of fat is associated with a state of chronic 
low-grade infl ammation. One of the potentially interesting aspects of our examination is 
that obesity in dogs is related to the decrease of BUN and creatinine concentration in 
the circulation. This condition may be a consequence of glomerular hyperfi ltration that 
could lead to further metabolic disorders associated with obesity. Overweight and obesity 
in the investigated dogs were characterized by disturbances in glucose metabolism and 
dyslipidemia, as previously reported. Further insight into the mechanisms involved in 
protection from atherosclerosis, stroke and diabetes in canine species could contribute to 
a better understanding of the causes of development of these disorders in other species, 
including humans.
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SAŽETAK
Prevelika tjelesna težina i pretilost povezane su s mnogobrojnim poremećajima u mnogih vrsta životinja. 
Da bi istražili promjene do kojih dolazi kod povećane tjelesne težine i pretilosti pasa, autori su prospektivno 
istražili hematološke i biokemijske pokazatelje u 45 pasa s povećanom tjelesnom težinom i pretilošću i usporedili 
rezultate dobivene u 28 zdravih pasa s normalnom tjelesnom masom. Broj neutrofi la, koncentracija ukupnog 
kolesterola i aktivnost alkalne fosfataze bili su povećani u skupini pasa s prevelikom tjelesnom masom i skupini 
pretilih pasa (P<0,01; P<0,007; P<0,000007), dok je koncentracija ureje bila snižena (P<0,007). Povećana 
tjelesna težina pasa bila je popraćena povećanim brojem neutrofi la, povećanom koncentracijom kolesterola 
i trigliceridima (P<0,03; P<0,00005; P<0,02), a pretilost je rezultirala povećanjem glukoze, alkalne fosfataze 
i kolesterola (P<0,02; P<0,002; P<0,0004) i snižavanjem ureje i kreatinina (P<0,0004; P<0,004). Dobiveni 
rezultati idu u prilog mišljenju da neutrofi li mogu imati ulogu u patološkim procesima uzrokovanim pretilošću. 
Povećana tjelesna težina i pretilost očitovali su se poremećajima u metabolizmu glukoze i dislipidemijom. Jedan 
od zanimljivih rezultata ovog istraživanja je povezanost pretilosti i smanjenja koncentracije ureje i kreatinina 
u krvotoku, što može biti posljedica povećane glomerularne fi ltracije ili hiperlipidemije. Istraživanje ukazuje 
da pretilost pasa značajno utječe na aktivnost alkalne fosfataze. Većina zdravstvenih problema u pasa može se 
uspješno spriječiti održavanjem normalne tjelesne težine. 
Ključne riječi: pas, pretilost, neutrofi li, glukoza, dislipidemija________________________________________________________________________________________
